The Annals
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

DICP, The Annals of Pharmacotherapy: Vol. 24, No. 10, pp. 982-989.
© 1990 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jankel, C.
Right arrow Articles by Speedie, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jankel, C.
Right arrow Articles by Speedie, S.

Research Articles

Detecting drug interactions: a review of the literature

CA Jankel and SM Speedie

This article provides a historic overview of drug interaction screening and reviews 19 studies that have sought to measure the frequency of drug interactions. Differences in study designs, methodologies, and definitions contribute to considerable variation in the reported incidence rates, which ranged from 2.2 to 70.3 percent for all potential drug interactions. The percentage of patients actually experiencing symptoms that could be attributed to a drug interaction, however, ranged from 0 to 11.1 percent. The relative importance of drug interactions as a clinical problem remains unclear. Screening programs that do more than simply identify large numbers of patients who receive potentially interacting drug combinations without indicating which subpopulations of these individuals are likely to be harmed by the drugs have not yet been developed.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
T. L Humphries, N. Carroll, E. A Chester, D. Magid, and B. Rocho
Evaluation of an Electronic Critical Drug Interaction Program Coupled with Active Pharmacist Intervention
Ann. Pharmacother., December 1, 2007; 41(12): 1979 - 1985.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
M. Mahmood, D. C. Malone, G. H. Skrepnek, J. Abarca, E. P. Armstrong, J. E. Murphy, A. J. Grizzle, Y. Ko, and R. L. Woosley
Potential drug-drug interactions within Veterans Affairs medical centers
Am. J. Health Syst. Pharm., July 15, 2007; 64(14): 1500 - 1505.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
D. C. Malone, D. S. Hutchins, H. Haupert, P. Hansten, B. Duncan, R. C. Van Bergen, S. L. Solomon, and R. B. Lipton
Assessment of potential drug-drug interactions with a prescription claims database
Am. J. Health Syst. Pharm., October 1, 2005; 62(19): 1983 - 1991.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. C. Peng, P. A. Glassman, L. E. Trilli, J. Hayes-Hunter, and C. B. Good
Incidence and Severity of Potential Drug-Dietary Supplement Interactions in Primary Care Patients: An Exploratory Study of 2 Outpatient Practices
Arch Intern Med, March 22, 2004; 164(6): 630 - 636.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1990 by Harvey Whitney Books Company.